CNSP
Cns Pharmaceuticals
$4.77
+$0.26 (+5.76%)Oct 29, 2026
Key metrics
The numbers that frame CNSP today
- Market cap
- $6.97M
- ROIC
- 995.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.90
- 52wk High
- $10.54
Growth
Revenue and earnings trend for CNSP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CNSP
Is Cns Pharmaceuticals a good buy?
Hold. Cns Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together.
What is the market capitalization of CNSP?
Cns Pharmaceuticals's market capitalization is $6.97M.
What is the 52-week high for CNSP stock?
The 52-week high for Cns Pharmaceuticals is $10.54. The current close of $4.77 is 54.7% below that high.
What is the 52-week low for CNSP stock?
The 52-week low for Cns Pharmaceuticals is $1.90. The current close of $4.77 is 151.1% above that low.
Does CNSP stock pay dividends?
Cns Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CNSP?
Cns Pharmaceuticals's Debt / Equity ratio is 0.